Search Results - "Nisticò, Paola"
-
1
Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer
Published in Frontiers in immunology (11-04-2019)“…Polyphenolic compounds, widely present in fruits, vegetables, and cereals, have potential benefits for human health and are protective agents against the…”
Get full text
Journal Article -
2
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
Published in Journal of experimental & clinical cancer research (18-05-2020)“…Tumor-infiltrating immune cells play a key role against cancer. However, malignant cells are able to evade the immune response and establish a very complex…”
Get full text
Journal Article -
3
Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology
Published in Journal of experimental & clinical cancer research (17-03-2021)“…Deciphering extracellular matrix (ECM) composition and architecture may represent a novel approach to identify diagnostic and therapeutic targets in cancer…”
Get full text
Journal Article -
4
Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting
Published in Cytokine & growth factor reviews (01-08-2017)“…Graphical abstract…”
Get full text
Journal Article -
5
Biological mechanisms linked to inflammation in cancer: Discovery of tumor microenvironment-related biomarkers and their clinical application in solid tumors
Published in The International journal of biological markers (01-02-2020)“…Our view of cancer biology radically shifted from a “cancer-cell-centric” vision to a view of cancer as an organ disease. The concept that genetic and/or…”
Get full text
Journal Article -
6
T-cell repertoire diversity: friend or foe for protective antitumor response?
Published in Journal of experimental & clinical cancer research (22-12-2022)“…Profiling the T-Cell Receptor (TCR) repertoire is establishing as a potent approach to investigate autologous and treatment-induced antitumor immune response…”
Get full text
Journal Article -
7
3D models in the new era of immune oncology: focus on T cells, CAF and ECM
Published in Journal of experimental & clinical cancer research (22-03-2019)“…Immune checkpoint inhibitor therapy has changed clinical practice for patients with different cancers, since these agents have demonstrated a significant…”
Get full text
Journal Article -
8
Transcription factors in fibroblast plasticity and CAF heterogeneity
Published in Journal of experimental & clinical cancer research (20-12-2023)“…In recent years, research focused on the multifaceted landscape and functions of cancer-associated fibroblasts (CAFs) aimed to reveal their heterogeneity and…”
Get full text
Journal Article -
9
A Systematic Review on the Impact of Hypofractionated and Stereotactic Radiotherapy on Immune Cell Subpopulations in Cancer Patients
Published in Cancers (22-10-2022)“…We investigated how hypofractionated radiotherapy (HFRT) and stereotactic body radiotherapy (SBRT) may impact immune cells in different type of tumors. A…”
Get full text
Journal Article -
10
Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases
Published in Cold Spring Harbor perspectives in biology (01-02-2012)“…Epithelial-mesenchymal transition (EMT) is a physiological process in which epithelial cells acquire the motile and invasive characteristics of mesenchymal…”
Get full text
Journal Article -
11
Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy
Published in Cancers (27-09-2022)“…The tumor stroma, which comprises stromal cells and non-cellular elements, is a critical component of the tumor microenvironment (TME). The dynamic…”
Get full text
Journal Article -
12
Actin Cytoskeleton and Regulation of TGFβ Signaling: Exploring Their Links
Published in Biomolecules (Basel, Switzerland) (23-02-2021)“…Human tissues, to maintain their architecture and function, respond to injuries by activating intricate biochemical and physical mechanisms that regulates…”
Get full text
Journal Article -
13
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis
Published in Journal of hematology and oncology (13-01-2017)“…We have previously shown that in pancreatic ductal adenocarcinoma (PDA) cells, the glycolytic enzyme alpha-enolase (ENO1) also acts as a plasminogen receptor…”
Get full text
Journal Article -
14
Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors
Published in Proceedings of the National Academy of Sciences - PNAS (20-11-2012)“…Human mena (hMENA), a member of the actin cytoskeleton regulators Ena/VASP, is overexpressed in high-risk preneoplastic lesions and in primary breast tumors…”
Get full text
Journal Article -
15
CD28/PD1 co-expression: dual impact on CD8 + T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response
Published in Journal of experimental & clinical cancer research (28-10-2023)“…Immune checkpoint blockade (ICB) has significantly prolonged survival of non-small cell lung cancer (NSCLC) patients, although most patients develop mechanisms…”
Get full text
Journal Article -
16
Cancer immunity and immunotherapy beyond COVID-19
Published in Cancer Immunology, Immunotherapy (01-07-2023)Get full text
Journal Article -
17
Stereotactic Ablative Radiation Therapy in 3 Fractions Induces a Favorable Systemic Immune Cell Profiling in Prostate Cancer Patients
Published in Oncoimmunology (31-12-2023)“…The impact of radiotherapy (RT) on immune cell status in prostate cancer (PCa) is only partially determined. The aim of this study was to assess the effect of…”
Get full text
Journal Article -
18
ADA/CD26 axis increases intra-tumor PD-1 + CD28 + CD8 + T-cell fitness and affects NSCLC prognosis and response to ICB
Published in Oncoimmunology (31-12-2024)“…Improving cancer immunotherapy efficacy hinges on identifying key T-cell populations critical for tumor control and response to Immune Checkpoint Blockade…”
Get full text
Journal Article -
19
Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC
Published in Lung cancer (Amsterdam, Netherlands) (01-08-2024)Get full text
Journal Article -
20
Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer
Published in Cancer research (Chicago, Ill.) (01-04-2024)“…Artificial intelligence (AI)-powered approaches are becoming increasingly used as histopathologic tools to extract subvisual features and improve diagnostic…”
Get full text
Journal Article